AI情报May 15, 2026AI情报
文章
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
AI 生成：摘要由 AI 根据所链接的来源撰写。 我们如何使用 AI
AI 生成来源: PR Newswire
01
来源简报
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.